Vericel Corp. (VCEL)
40.96
-0.22
(-0.53%)
USD |
NASDAQ |
Aug 28, 16:00
40.93
-0.03
(-0.07%)
After-Hours: 20:00
Vericel Cash from Operations (Quarterly) : 16.19M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.19M |
| March 31, 2026 | 16.38M |
| December 31, 2025 | 15.01M |
| September 30, 2025 | 22.08M |
| June 30, 2025 | 8.214M |
| March 31, 2025 | 6.60M |
| December 31, 2024 | 22.24M |
| September 30, 2024 | 10.18M |
| June 30, 2024 | 18.54M |
| March 31, 2024 | 7.202M |
| December 31, 2023 | 10.09M |
| September 30, 2023 | 7.169M |
| June 30, 2023 | 10.20M |
| March 31, 2023 | 7.86M |
| December 31, 2022 | 6.975M |
| September 30, 2022 | 3.025M |
| June 30, 2022 | 3.143M |
| March 31, 2022 | 3.468M |
| December 31, 2021 | 10.55M |
| September 30, 2021 | 3.634M |
| June 30, 2021 | 4.769M |
| March 31, 2021 | 10.09M |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 4.57M |
| June 30, 2020 | -3.021M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.686M |
| December 31, 2019 | 3.15M |
| September 30, 2019 | 7.892M |
| June 30, 2019 | -18.38M |
| March 31, 2019 | 0.154M |
| December 31, 2018 | 2.611M |
| September 30, 2018 | 2.013M |
| June 30, 2018 | -5.441M |
| March 31, 2018 | 0.405M |
| December 31, 2017 | 0.834M |
| September 30, 2017 | -5.241M |
| June 30, 2017 | -5.654M |
| March 31, 2017 | -3.122M |
| December 31, 2016 | -9.308M |
| September 30, 2016 | -4.182M |
| June 30, 2016 | -5.133M |
| March 31, 2016 | -1.269M |
| December 31, 2015 | -4.037M |
| September 30, 2015 | -0.718M |
| June 30, 2015 | -4.478M |
| March 31, 2015 | -4.113M |
| December 31, 2014 | -6.244M |
| September 30, 2014 | -8.423M |
| June 30, 2014 | -6.069M |
| March 31, 2014 | -4.674M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| AbbVie, Inc. | 3.436B |
| ADMA Biologics, Inc. | 29.54M |
| Kyntra Bio, Inc. | -3.991M |
| Conexeu Sciences, Inc. | -1.804M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.82M |
| Cash from Financing (Quarterly) | 2.692M |
| Free Cash Flow | 61.66M |
| Free Cash Flow Per Share (Quarterly) | 0.2726 |
| Free Cash Flow to Equity (Quarterly) | 16.11M |
| Free Cash Flow to Firm (Quarterly) | 14.42M |
| Free Cash Flow Yield | 2.91% |